Pramipexole is a member of the class of benzothiazoles that is 4,5,6,7-tetrahydro-1,3-benzothiazole in which the hydrogens at the 2 and 6-pro-S-positions are substituted by amino and propylamino groups, respectively. Among its listed roles, it functions as a antiparkinson drug, a dopamine agonist, an antidyskinesia agent and a radical scavenger. It is grouped under the following drug class(es): Dopamine agents. Its therapeutic use is listed as antiparkinsonian agents and central nervous system (CNS) agents. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Mirapexin, Sifrol, Neliprax and Pipexus. Its PubChem CID is 119570.
Pramipexole
| CAS No | 104632-26-0 |
|---|---|
| Molecular Formula | C10H17N3S |
| Molecular Weight | 211.33 g/mol |
| Synonyms | (6S)-6-N-propyl-4,5,6,7-tetrahydro-1,3-benzothiazole-2,6-diamine |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Pramipexole is a member of the class of benzothiazoles that is 4,5,6,7-tetrahydro-1,3-benzothiazole in which the hydrogens at the 2 and 6-pro-S-positions are substituted by amino and propylamino groups, respectively.
The listed CAS number is 104632-26-0.
The listed molecular formula is C10H17N3S.
The listed molecular weight is 211.33 g/mol.
(6S)-6-N-propyl-4,5,6,7-tetrahydro-1,3-benzothiazole-2,6-diamine.
The source lists Mirapexin, Sifrol, Neliprax and Pipexus.